June 17 (Reuters) - Bayer said Teva's U.S. unit admitted in a court proceeding on Wednesday that some of the information included on packages of its oral contraceptive Gianvi was false and agreed to ...
- Bayer's lawsuit under the Federal False Advertising Act (the Lanham Act) results in Teva agreement to make three months of weekly communications to pharmacists to correct false labels In response to ...
Teva Pharmaceuticals in the US has admitted to including false statements in the physician prescribing information for its oral contraceptive product Gianvi, a generic version of Bayer Healthcare?s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results